Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-1,953,037
Closed -$703K 3529
2025
Q3
$703K Buy
1,953,037
+189,155
+11% +$77.8K ﹤0.01% 2099
2025
Q2
$794K Buy
+1,763,882
New +$767K ﹤0.01% 1947
2024
Q4
Sell
-67,484
Closed -$57.4K 3047
2024
Q3
$57.4K Sell
67,484
-179,930
-73% -$138K ﹤0.01% 2412
2024
Q2
$166K Sell
247,414
-285,665
-54% -$237K ﹤0.01% 2333
2024
Q1
$693K Buy
+533,079
New +$559K ﹤0.01% 1802

Other funds holding VXRT

Marshall Wace's VXRT Position: Q4 2025 in Review

Marshall Wace sold out of Vaxart (VXRT) in Q4 2025, closing a stake of 1,953,037 shares — an estimated $703K sold.

Marshall Wace first reported a position in VXRT in Q1 2024 and held it in 5 quarters. The position peaked at $794K in Q2 2025. 5 funds tracked by Wall St. Rank hold VXRT as of Q4 2025.

  • Marshall Wace reported no remaining Vaxart position as of Q4 2025 after selling out during the quarter.
  • Marshall Wace sold 1,953,037 Vaxart shares in Q4 2025, an estimated $703K.
  • Marshall Wace first reported a position in Vaxart in Q1 2024 and held it in 5 quarters.
  • Marshall Wace's Vaxart position peaked at $794K in Q2 2025.
  • 5 funds tracked by Wall St. Rank held Vaxart as of Q4 2025.

Based on Marshall Wace's 13F filing for Q4 2025, filed 13 Feb 2026.